Terms: = Colorectal cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Treatment
1273 results:
1. Feasibility of implementation of the early tumor shrinkage as a potential predictive marker to daily clinical practice in patients with RAS wild type metastatic colorectal cancer, treated with cetuximab - a non-interventional observational study.
Fínek J; Vočka M; Bauer J; Kubala E; Zycháčková K; Šedivá M; Gharibyar M; Kocáková I; Čmuchařová E; Vaňková M
Klin Onkol; 2024; 38(2):110-117. PubMed ID: 38697819
[TBL] [Abstract] [Full Text] [Related]
2. Genetic and microbial determinants of azoxymethane-induced colorectal tumor susceptibility in Collaborative Cross mice and their implication in human cancer.
Li D; Zhong C; Yang M; He L; Chang H; Zhu N; Celniker SE; Threadgill DW; Snijders AM; Mao JH; Yuan Y
Gut Microbes; 2024; 16(1):2341647. PubMed ID: 38659246
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell analysis revealed a potential role of T-cell exhaustion in colorectal cancer with liver metastasis.
Ling T; Zhang C; Liu Y; Jiang C; Gu L
J Cell Mol Med; 2024 Apr; 28(8):e18341. PubMed ID: 38647235
[TBL] [Abstract] [Full Text] [Related]
4. Immune checkpoint inhibitors in cancer patients with rheumatologic preexisting autoimmune diseases: a systematic review and meta-analysis.
Liu X; Li S; Ke L; Cui H
BMC Cancer; 2024 Apr; 24(1):490. PubMed ID: 38632528
[TBL] [Abstract] [Full Text] [Related]
5. The prognostic value of sialylation-related long non-coding RNAs in lung adenocarcinoma.
Wang B; Hou C; Yu X; Liu J; Wang J
Sci Rep; 2024 Apr; 14(1):8879. PubMed ID: 38632255
[TBL] [Abstract] [Full Text] [Related]
6. Exploring treatment outcomes in Stage II-III rectal cancer patients undergoing neoadjuvant therapy at a tertiary care center in Pakistan: a comprehensive analysis of pathological outcomes.
Soomro MY; Khan SR; Muhammad H; Ahmad S; Zehra N; Ali I; Samar MR; Hameed A; Moosajee M; Rashid YA
BMC Cancer; 2024 Apr; 24(1):479. PubMed ID: 38627736
[TBL] [Abstract] [Full Text] [Related]
7. Tumor mutational burden in colorectal cancer: Implications for treatment.
Marques A; Cavaco P; Torre C; Sepodes B; Rocha J
Crit Rev Oncol Hematol; 2024 May; 197():104342. PubMed ID: 38614266
[TBL] [Abstract] [Full Text] [Related]
8. Synthetic Derivatives of Natural
Badalamenti N; Maggio A; Fontana G; Bruno M; Lauricella M; D'Anneo A
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612735
[TBL] [Abstract] [Full Text] [Related]
9. Identification and validation of regulatory T cell-associated gene signatures to predict colon adenocarcinoma prognosis.
Zhao X; Li X; Miao Z
Int Immunopharmacol; 2024 May; 132():112034. PubMed ID: 38588631
[TBL] [Abstract] [Full Text] [Related]
10. A new clinical model for predicting lymph node metastasis in T1 colorectal cancer.
Wang K; He H; Lin Y; Zhang Y; Chen J; Hu J; He X
Int J Colorectal Dis; 2024 Apr; 39(1):46. PubMed ID: 38565736
[TBL] [Abstract] [Full Text] [Related]
11. Spouses of patients treated for colon cancer: identification of key caregiver skills using the Delphi method.
Le Roux E; Meunier-Beillard N; Simonel C; Omorou A; Lejeune C
Support Care Cancer; 2024 Apr; 32(4):263. PubMed ID: 38564042
[TBL] [Abstract] [Full Text] [Related]
12. Mechanistic insights into FEN1-mediated drug sensitivity and risk signature in colon cancer: An integrative bioinformatics study.
Rao C; Tong J; Yang Y
Medicine (Baltimore); 2024 Mar; 103(13):e37517. PubMed ID: 38552056
[TBL] [Abstract] [Full Text] [Related]
13. Identification of Genomic Signatures for colorectal cancer Survival Using Exploratory Data Mining.
Hummel JJ; Liu D; Tallon E; Snyder J; Warren W; Shyu CR; Mitchem J; Cortese R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542194
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Subtypes, microRNAs and Immunotherapy Response in Metastatic colorectal cancer.
Gherman A; Bolundut D; Ecea R; Balacescu L; Curcean S; Dina C; Balacescu O; Cainap C
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541123
[TBL] [Abstract] [Full Text] [Related]
15. Habitat-based radiomics analysis for evaluating immediate response in colorectal cancer lung metastases treated by radiofrequency ablation.
Huang H; Chen H; Zheng D; Chen C; Wang Y; Xu L; Wang Y; He X; Yang Y; Li W
Cancer Imaging; 2024 Mar; 24(1):44. PubMed ID: 38532520
[TBL] [Abstract] [Full Text] [Related]
16. International consensus is needed on a core outcome set to advance the evidence of best practice in cancer prehabilitation services and research.
Myers AM; Barlow RC; Baldini G; Campbell AM; Carli F; Carr EJ; Collyer T; Danjoux G; Davis JF; Denehy L; Durrand J; Gillis C; Greenfield DM; Griffiths SP; Grocott M; Humphreys L; Jack S; Keen C; Levett DZH; Merchant Z; Moore J; Moug S; Ricketts W; Santa Mina D; Saxton JM; Shaw CE; Tew GA; Thelwell M; West MA; Copeland RJ
Br J Anaesth; 2024 May; 132(5):851-856. PubMed ID: 38522964
[TBL] [Abstract] [Full Text] [Related]
17. treatment Options for Distal Rectal cancer in the Era of Organ Preservation.
Wang C; Liu X; Wang W; Miao Z; Li X; Liu D; Hu K
Curr Treat Options Oncol; 2024 Apr; 25(4):434-452. PubMed ID: 38517596
[TBL] [Abstract] [Full Text] [Related]
18. Radiomics-enhanced early regression index for predicting treatment response in rectal cancer: a multi-institutional 0.35 T MRI-guided radiotherapy study.
Boldrini L; Chiloiro G; Cusumano D; Yadav P; Yu G; Romano A; Piras A; Votta C; Placidi L; Broggi S; Catucci F; Lenkowicz J; Indovina L; Bassetti MF; Yang Y; Fiorino C; Valentini V; Gambacorta MA
Radiol Med; 2024 Apr; 129(4):615-622. PubMed ID: 38512616
[TBL] [Abstract] [Full Text] [Related]
19. Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patients.
Barbe R; Belkouchi Y; Menu Y; Cohen R; David C; Kind M; Harguem S; Dawi L; Hadchiti J; Selhane F; Billet N; Ammari S; Bertin A; Lawrance L; Cervantes B; Hollebecque A; Balleyguier C; Cournede PH; Talbot H; Lassau N; Andre T
Eur J Cancer; 2024 May; 202():114020. PubMed ID: 38502988
[TBL] [Abstract] [Full Text] [Related]
20. PANoptosis-related genes function as efficient prognostic biomarkers in colon adenocarcinoma.
Liu Y; Wang Y; Feng H; Ma L; Liu Y
Front Endocrinol (Lausanne); 2024; 15():1344058. PubMed ID: 38501104
[TBL] [Abstract] [Full Text] [Related]
[Next]
